Analysts Offer Insights on Healthcare Companies: Amneal Pharmaceuticals (AMRX), Aura Biosciences Inc (AURA) and Terns Pharmaceuticals (TERN)
Terns Pharmaceuticals Shares Fall After Pricing of Public Offering
Terns Pharmaceuticals Shares Are Trading Lower After the Company Announced It Priced a $150.1 Million Public Offering of 11,919,048 Shares at $10.50 per Share.
Daily options tracking | Bullish betting on Tesla calls is active again! Deutsche Bank 'switches from short to long' and is bullish on its rise by over 30%; JPMorgan's stock price unexpectedly fell, making big profits on multiple put options.
The market is paying attention to Huang Renxun's speech on Wednesday. Large investors sold 13.2341 million USD call options to take a bearish view. Reverse operation? Gamestop now has two large call option orders. After the earnings release, the night market fell more than 10%.
Terns Pharmaceuticals: Gross Proceeds Expected to Be Approximately $150.15M >TERN
Terns Pharmaceuticals: Certain Investors Offered Pre-Funded Warrants to Purchase 2.4M Shares at $10.4999 Per Pre-Funded Warrant >TERN